Releaf

Santa’s Wish List: A Dreamy Recap of “I Had A Dream Series - UK Prescription Cannabis” Huddle up, holiday elves! It’s time to sleigh through a recap of my “I Had a Dream Series”2024 and unwrap our wish list for a magical 2025! Think mistletoe, myths, and merry solutions, all wrapped in a bow. Let’s unwrap this festive dream, one at a time. Misinformation Mania: The Ghost of Myths Past Forget the holiday rumors, prescription cannabis isn’t a miracle cure-all. Trust data, not Santa-sized hearsay! We’re sleighing the falsehoods with cold, hard facts. The Growth That Got Grinched The cannabis industry’s potential is as bright as Christmas lights… but bureaucracy is playing Scrooge. Red tape, financial frosts, and expertise in short supply? Misleading Moves: Who’s on the Naughty List Dodgy lobbying, poor quality, and unreliable healthcare service coupled with subpar supply have been stuffing the industry’s stocking with coal. It’s time for industry to tidy up this chimney of chaos. Patient Choice: Frostbitten Dreams A prescription isn’t much of a gift when patients can’t actually access their meds. The gap needs fixing faster than Santa’s sleigh on Christmas Eve. Consistency is King: Clinics to the Rescue The elves of the cannabis world? Vertically integrated clinics - Releaf Glass Pharms their ensuring quality, streamlining care, and delivering solutions that sparkle brighter than a star on the tree. Tracking Triumphs: Data to the Rescue Like Rudolph’s nose lighting the way, clinics tracking patient outcomes are guiding the industry to evidence-based care. Proof beats hype, every time. Accessibility Elevated: All Aboard the Sleigh From consultation to treatment, the best clinics are decking the halls with patient-first systems. True accessibility isn’t just about getting there - it’s about getting better. Specialised Consultants: Industry MVPs Move over, Santa! Specialist medical cannabis consultants are the true legends. They’re crafting tailored care that’s the ultimate gift for patients. Unbiased Forums: Safe Spaces, Please! Patients need places to share stories without all the tinsel and spin. Honest, open forums? Cannabis niave patients cosy! Consider it another of our Christmas wish’s. Regulations Gone Rogue: Naughty Rules The UK’s regulations are more tangled than Christmas lights- giving some industry elves the perfect “get out Claus” to avoid following the rules. Let’s dream of a world where these naughty elves move onto Santa’s nice list! Dreams may be the twinkling lights, but let action be the shining star! Together, let’s light the way to a joyful and brighter future for prescription cannabis in 2025. Wishing you all the sparkle, cheer, and magic this Christmas and may all your holiday wishes sleigh their way into reality in 2025!

Releaf HealthTech is reshaping the #UK’s medical cannabis sector by focusing on behaviours over results. Speaking to Business of Cannabis, CEO Tim Kirby explained that their proprietary HealthTech platform—developed with a £2M pre-revenue investment—was designed to drive high-performance behaviours through real-time data insights. This approach has made Releaf the fastest-growing and most trusted medical cannabis provider in the UK, with the highest Trustpilot ratings and patient advocacy in the sector. Releaf’s focus on patient outcomes and experience is evident in innovations like their newly launched Patient Portal V2. Kirby stressed that success isn’t about chasing results but understanding and replicating the behaviours that deliver exceptional patient care. Read the full story here: https://lnkd.in/ddnbXmt4 #CannabisNews #HealthTech #PatientCare

Welcome to final installment - I Had A Dream Series: Regulatory Challenges: How UK Prescription Cannabis regulations have impacted patient care Since its much celebrated legalisation in 2018, the prescription cannabis scene in the UK has been like a promising new show bogged down by terrible reviews, thanks to the star performers: regulatory hurdles and some of the industries bad practices. What was meant to be a game-changer for patient care has turned into a bureaucratic obstacle course assisted by some companies providing dodgy healthcare leaving patients and doctors scrambling for solutions. Let’s talk Schedule 2 drugs. This classification under the Misuse of Drugs Regulations 2001 sounds official and it is, but here’s the kicker: while cannabis-based medicines can be prescribed, only specialists get the golden ticket to do so. General practitioners? Nope, they’re benched. Specialists, meanwhile, are often untrained, half-trained, nervous, or both. The result? Long waits, frustrated patients, and a system that moves slower than a snail on sedatives. Then there’s NICE (that’s the National Institute for Health and Care Excellence, ironically). NICE has greenlit cannabis-based medicines, but only for a tiny selection of conditions. Rare epilepsies, multiple sclerosis, and chemo-induced nausea. Chronic pain? NHS access ? Forget about it. This leaves a whole host of patients stuck in the no-hope-for-you line, while other countries have already embraced prescription cannabis as a go-to option for pain relief. Even for those who do qualify, there’s another plot twist: finding quality medicine. Licensed cannabis products are as rare as sunshine in a British winter. Patients dive into their own pockets to pay privately, opening the door for certain, but not all providers to offer imported meds that might come with a side of mold, a sprinkle of insects, a dash of seeds, or other funky surprises. Recipe for some serious head scratching over the quality and safety standards in some of these private clinics. MHRA- dreaming of a white Christmas? To make things worse, healthcare professionals are flying blind. Training? Minimal. Clear guidelines? Conveniently ignored. Confidence in prescribing? Questionable in some practices. The result? A vicious cycle of uncertainty that keeps patients waiting, doctors hesitating, and cannabis gathering dust in a bureaucratic limbo. This tangled web of red tape, meant to ensure safety, has morphed into a straitjacket for patient care. If the UK wants to unlock the real potential of Prescription Cannabis it’s time to cut the red tape, broaden the guidelines, educate clinicians better. Some industry players need to wrap it up like a perfect Christmas present and stop behaving like they’re running Santa’s candy shop! Until then, patients will remain stuck in this regulatory maze exploited by the “Grinch” who just took all your Christmas Amazon packages.

Welcome to my I Had A Dream Series: Installment 10 - Open Forums on Prescription Cannabis: The need for unbiased patient platforms. Let’s face it Prescription Cannabis is going mainstream, and the buzz (pun totally intended) is real. Countries are loosening up, research is booming, and laws are catching up. But here’s the kicker: there’s a lack of unbiased forums for patients to swap stories, ask burning questions, and get the tea on what actually works. Yep, we’re talking open, no-judgment zones for the cannabis-naive and the medically motivated. Why Do We Care? Because Open Forums Are a Big Deal For some folks, prescription cannabis is the last Hail Mary when other meds just don’t cut it. But instead of clarity, they get drowned in half-baked info and stigma leftovers. That’s why open forums need to exist. Safe judgment-free zones where even the most cannabis-naïve can ask, “What’s a tincture, and why does everyone talk about high THC flowers like they’re the “final boss?” These forums can also bridge the gap between lab coats and real-life users. Clinical trials are great and all, but they often miss the juicy details: the weird side effects, surprising benefits, and that time someone’s grandma administered an edible and became couch locked. Real talk = real insights. Unbiased or Busted: The Real Deal with Open Platforms Here’s the catch: forums can easily go from real medical stories to infomercial nightmares! The cannabis industry is growing faster than the tech boom of the 2000’s and some companies can’t resist sneaking in to push their products. An unbiased forum? It’s like the Holy Grail - focused on patients, not profits. Plus, let’s get some actual experts in the room. Think myth-busting moderators who know the difference between THC and “that stuff my cousin swears cured his dog’s arthritis.” It’s about serving facts, not fluff. So, What’s Next? The Game Plan If we’re going to do this right, we need a squad: patients, docs, researchers and advocates in the same forum all working together. Non-profits and government backing wouldn’t hurt either. Think Kickstarter, but for knowledge-sharing. The endgame? A world where talking about prescription cannabis feels as normal as asking your local cafe for oat milk. Open, unbiased forums could smash stigma, level up patient care, and finally answer the question, “Is it normal to feel my anxiety escalate after one dose?” Prescription Cannabis patients need safe spaces to chat without judgment and recreational users gate crashing! Like in a book club - just to talk about movie adaptations, for them it’s fun! Disruptive and confusing for those who came for the actual chapters. Let’s make it happen, one real medical , unbiased platform at a time. We’ve kicked things off - now it’s your turn to jump in and join us. Billy & Charlotte x https://lnkd.in/dykS7ckB

Business of Cannabis: Podcast | Releaf x SOMAÍ Pharmaceuticals 🎙 Next up we have a special episode with Tim Kirby, Chief Executive Officer with Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals. Join us as our Business of Cannabis guests discuss the highs and lows of the industry from the United States to Europe, they share the skills required to navigate the cannabis market, and how they hope the future of cannabis will take shape over the next few years. Youtube 📹 👉 https://lnkd.in/eYRbGEfW Spotify 🎧 👉 https://lnkd.in/dA_nprKG #podcast #cannabispodcast #cannabisindustry

Welcome to I Had a Dream Series Installment 9 - Value in Care: Why Specialised Consultants Are the MVPs of Medical Cannabis The world of medical cannabis is blossoming faster than a spring garden, offering solutions for a variety of health conditions. But let’s face it, using cannabis as medicine isn’t as simple as picking up a pre-roll. Enter the heroes of the story: specialised doctor consultants. These experts are the GPS for patients navigating the winding roads of cannabis therapy. Experts in Building the Perfect Medical Cannabis Plan One size definitely doesn’t fit all, especially in medicine. Specialised consultants are like personal trainers for your health. They dig into your medical history, symptoms, and treatment responses to craft a plan that’s just right for you. From choosing the right strain to nailing the perfect dosage, they ensure your cannabis journey is safe, effective, and totally personalised. Cracking the Medical Cannabis Code Cannabis isn’t just one plant - it’s a chemistry set full of cannabinoids, terpenes, and delivery options. Trying to figure it out solo? That’s like solving a Rubik’s cube blindfolded. These consultants geek out over the science so you don’t have to, turning complex pharmacology into clear, actionable steps for your treatment. Safety First, Always The legal and regulatory world of medical cannabis is, let’s be honest, a bit of a maze. Specialised consultants are your compliance coaches, guiding you through local laws, protocols, and potential pitfalls. They don’t just set you up and wish you luck - they stick around, monitoring your progress and tweaking treatments to keep you on the safest, most effective path. Medical Cannabis School: Empowering Patients Knowledge is power, and these consultants are all about sharing the wealth. They break down the pros, cons, and everything in between so you can make informed decisions about your health. With their guidance, you’re not just a patient, you’re an empowered partner in your care. A Blend of Old and New Think of these specialists as medical mixologists, blending the best of traditional treatments with cutting-edge prescription cannabis therapies. They focus on holistic healing, putting your overall well-being front and center. It’s not just about symptom relief; it’s about thriving long-term. Medical cannabis is brimming with potential, but it needs expert pilots to chart the course. With specialised consultants leading the way, patients can embrace this therapeutic frontier with confidence, clarity, and a touch of quirkiness.

Releaf Clinic's compliance lead, Rupa Shah, and operational training expert, Graham Woodward RNMH FCMI, shared how the company seamlessly integrates CAP Code adherence and ASA regulations with a patient-first approach. They emphasise that compliance is embedded into the company culture from onboarding to daily operations, fostering trust and transparency. Releaf also tackles stigma through clinician education, offering evidence-based resources and free training for healthcare professionals starting in 2025. By equipping their team and external clinicians with the tools to navigate this complex sector, Releaf aims to raise industry standards and reduce misconceptions about cannabis-based medicines. Read here: https://lnkd.in/dV-dPnrB 👉 How do you think compliance impacts patient trust in emerging healthcare sectors? Let us know in the comments below.

Welcome to “I Had a Dream” Series - Installment 8 Accessibility: Creating a seamless, patient-centered experience. So, here’s the tea: medical cannabis became legal in the UK in 2018. But for most patients, getting access to it feels like trying to find Narnia in a broom closet. Debilitating conditions? those demand a system that’s simple, stigma free, & dare we dream it? patient-friendly. What’s Holding Things Up? Medical cannabis might be legal, but the road to getting it - potholes, detours, & the occasional bureaucratic sinkhole. • Confusion Central: Patients & some doctors are lost in the weeds (pun intended) when it comes to eligibility & prescriptions. • Red Tape Wrangling: The hoops you have to jump through? Exhausting! • Bank Breaking Prices: Treatment costs can be sky-high. • Stigma-ville: Outdated mindsets still give cannabis the side-eye. • Quality Chaos: Inconsistent products and no-refund policies make trust in the industry shakier than a celeb doing a bush-tucker trial. Mission: Make Prescription Cannabis Actually Work for Patients Here’s what needs to happen to turn this maze into a straight path: 1. Simplify, Simplify, Simplify • One-Stop Shops: Imagine your clinic website where you book appointments, track treatments, track dispensing and get all the info you need. 2. Don’t Make It a Wallet-Wrecker • Subsidies & Insurance: NHS coverage, private insurance inclusion whatever it takes to make treatment affordable. • Compassion Discounts: Special rates for low-income patients because health shouldn’t depend on your bank balance. 3. Bye-Bye Stigma • Public Campaigns: It’s not “stoner culture”- it’s SCIENCE. Let’s reframe the narrative. • Doctor Training: Equip healthcare professionals with the knowledge to talk cannabis like pros. 4. Equity for Everyone • More Access: Expand fit for purpose clinics such as Releaf to every corner of the UK, especially underserved areas. • Inclusive Outreach: Make sure all communities, regardless of background, are in the loop & make cannabis naive patients inclusive. 5. Tech to the Rescue • Telemedicine: Virtual consultations for patients who can’t just pop down to a clinic. • Smart Systems: Use data to fine-tune treatments and improve care. The Dream Scenario Picture this: • Smooth Sailing: No red tape, just a straight shot from consultation to prescription to dispensing. • Affordable Options: Costs that won’t make your wallet cry. • A Strong Support Network: Financial aid, emotional backing, and logistical help all wrapped in a tidy bow. The solution isn’t rocket science - it’s medical science. Every patient deserves care that’s hassle-free, stigma-free, and doesn’t cost a small fortune. So, are you ready to roll up your sleeves & make this happen? Let’s dream big-be different and then make it real. Never.Follow.The.Herd.

ICYMI: Business of Cannabis Editor Ben Stevens interviews Graham Woodward RNMH FCMI, COO of Releaf, about the UK's rapidly growing medical cannabis industry. They explore the challenges posed by a shortage of trained cannabis-prescribing doctors, how Releaf addresses this with robust training programs and recruitment, and the importance of real-world data in advancing cannabis research. Woodward also shares details of an exciting collaboration with Leeds University to study cannabis’s effects on long COVID. Could better education and partnerships like this be the key to unlocking the industry's full potential? Find out below 👇 https://lnkd.in/eqkzqmj9